Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout
Introduction
Waters et al. [1]recently reviewed an extensive database on the activities of several antimutagens in vitro and in vivo, and summarized the results in the form of detailed `activity profiles'. Among the various inhibitors reviewed, chlorophyllin (CHL) was identified as almost uniformly protective against a broad range of direct- and indirect-acting mutagens, including aflatoxins, polycyclic aromatic hydrocarbons, heterocyclic amines, alkylating agents and several miscellaneous compounds. Close inspection of the data presented in the review indicates that the vast majority of experiments using CHL were from assays conducted in vitro, and in many cases these were descriptive rather than mechanistic studies. The antimutagenicity profile for CHL contained only 7 out of a total of 93 data points that were from experiments conducted in vivo. The limited nature of the in vivo data notwithstanding, most of the evidence strongly supported a protective role for CHL [1].
In the time since the review by Waters et al. [1]was submitted and published, several new in vivo studies with CHL have been reported. Perhaps most notable among these is the work that showed CHL to be a potent inhibitor of aflatoxin B1 (AFB1)-initiated tumorigenesis in rainbow trout [2]. This was the first evidence that CHL could operate not only as an antimutagen, but also as an anticarcinogen in some experimental protocols. The present paper reviews several of the key experiments with CHL and AFB1 in trout. In the context of this Special Issue on `The Use of Fish and Fish Transgenics in Genotoxicology Studies', the review serves to illustrate several of the advantages and limitations of rainbow trout as a model for investigating modulators of tumorigenesis and genotoxicity in vivo.
Section snippets
In vitro antimutagenic activity of CHL vs. AFB1 and AFB1-8,9-epoxide
The first studies with CHL in our laboratory used the Salmonella assay, and were based on preliminary experiments which examined the antimutagenic activity of CHL vs. AFB1 [3]. A key observation in the studies by Whong et al. [3]was that the inhibitory activity occurred only when CHL and AFB1 were incubated concurrently in the assay, suggesting that direct interaction between the inhibitor and mutagen might be important for antimutagenic activity. We observed the antimutagenic activity of CHL
Inhibition of AFB1-DNA binding in vivo
Previous work in our laboratory with AFB1 and the anticarcinogen indole-3-carbinol established that AFB1-DNA adducts increased linearly with time of carcinogen exposure during a 2-week dietary treatment of trout, and that the slopes of the DNA binding curves decreased with concentration of inhibitor in the diet [5]. Similar results were obtained in studies with CHL, in which trout were co-treated with AFB1 and the inhibitor for 7 days (Fig. 1b). In these experiments, CHL protected against AFB1
Inhibition of AFB1-DNA adducts and hepatocarcinogenesis (molecular dosimetry studies)
Rainbow trout (1–2 g body weight) were exposed in the diet to 0, 500, 2000, or 4000 ppm CHL and, within each inhibitor group, to one of four different doses of AFB1. The carcinogen was administered in tritiated form during a 2 week period and 15 fish were selected at random from each tank in order to determine AFB1-DNA binding levels in the liver. The remaining animals were switched to control diet and after 9 months 100 of the fish in each tank were selected at random in order to determine the
Interceptor molecule hypothesis
Hartman and Shankel [7]reviewed the literature for inhibitors that interact directly with mutagens and carcinogens and serve in effect to `sequester' these compounds from harm's way. By reducing the bioavailability of many genotoxins, these putative `interceptor molecules' might represent an important first line of defense, perhaps rivaling such mechanisms as induction of detoxification enzymes or inhibition of carcinogen activating enzymes. In the period since the review by Hartman and Shankel
AFB1-CHL complex formation
Evidence for the formation of an AFB1-CHL complex was first obtained in titration studies using a double-beam spectrophotometer. With the addition of AFB1 to the sample cuvette followed by subsequent additions of CHL to both cuvettes, quenching of the absorption spectrum of AFB1 occurred in a manner consistent with complex formation between the two molecules (Fig. 2). Because both compounds have absorption maxima in the region 200–400 nm, which might cause interference during spectrophotometric
Activity of natural chlorophylls in vitro and in vivo
Computer-modeling studies indicate that the tetrapyrrole macrocyclic is the most important feature for complex formation with AFB1, and that natural chlorophylls should be effective inhibitors. However, in contrast to CHL, which is highly water soluble, lipophilic natural chlorophylls complex less effectively with carcinogens under the aqueous conditions of many in vitro assays. A mixture of chlorophylls a and b was shown to exhibit antimutagenic activity in the Salmonella assay by a mechanism
Acknowledgements
The work reviewed here was supported in part by the following Public Health Service grants: CA65525, CA34732, ES03850 and ES00210.
References (24)
- et al.
Activity profiles of antimutagens: in vitro and in vivo data
Mutat. Res.
(1996) - et al.
Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity
Mutat. Res.
(1993) - et al.
Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen
Mutat. Res.
(1994) - et al.
Inhibitory effect of hemin, chlorophyllin and related pyrrole pigments on the mutagenicity of benzo[a]pyrene and its metabolites
Mutat. Res.
(1995) - et al.
Role of hemin in the inhibition of mutagenic activity of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and other aminoazaarenes
Mutat. Res.
(1989) - et al.
Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout
Cancer Res.
(1995) - et al.
Comparative anti-mutagenicity of chlorophyllin and five other agents against aflatoxin B1-induced reversion in Salmonella typhimurium strain TA98
Teratog. Carcinog. Mutag.
(1988) - et al.
Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay
Carcinogenesis
(1991) - et al.
Mechanisms of anti-carcinogenesis by indole-3-carbinol: Detailed in vivo DNA binding dose-response studies after dietary administration with AFB1
Carcinogenesis
(1988) - et al.
Quantitative interrelationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction, and final tumor response
Carcinogenesis
(1989)
Antimutagens and anticarcinogens: a survey of putative interceptor molecules
Environ. Mol. Mutagen.
Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA binding by chlorophyllin: studies of enzyme inhibition and molecular complex formation
Carcinogenesis
Cited by (117)
Spectroscopy studies of interaction hypericin with an anti-cancer therapy drug doxorubicin
2022, Biophysical ChemistryBiological activities of natural products from microalgae
2021, Cultured Microalgae for the Food Industry: Current and Potential ApplicationsPathological and biochemical evaluation of coumarin and chlorophyllin against aflatoxicosis in rat
2017, Experimental and Toxicologic PathologyInhibition effects of Chinese cabbage powder on aflatoxin B1-induced liver cancer
2015, Food ChemistryCitation Excerpt :Surface-modified clay additives can effectively bind aflatoxins in contaminated feed or food, thereby preventing toxicity. Research on chlorophylls has attracted widespread attention (Dashwood et al., 1998). In particular, naturally occurring chlorophyll derivatives inhibit AFB1-DNA adduct formation in both hepatoma cells and individuals at high risk for liver cancer (Hsu et al., 2008).
Electrogenerated chemiluminescence of magnesium chlorophyllin a aqueous solution and its sensitive response to the carcinogen aflatoxin B<inf>1</inf>
2014, Biosensors and BioelectronicsCitation Excerpt :Antimutagenic/anticarcinogenic mechanistic studies show that chlorophyllin can form tight molecular complexes with the carcinogens (Breinholt et al., 1995; Dashwood et al., 1996; Reddy et al., 1999). The formation of complex impedes carcinogen absorption and reduces bioavailability to the target tissue, thereby leading to less DNA adduction and lower tumor incidence (Dashwood et al., 1998). Based on the formation of the Chlorins a–AFB1 complex, the ECL response of Chlorins a aqueous solution for the carcinogen AFB1 was studied.
Culture of a high-chlorophyll-producing and halotolerant Chlorella vulgaris
2014, Journal of Bioscience and Bioengineering